INTERCEPT PHARMACEUTICALS IN's ticker is and the CUSIP is 45845PAA6. A total of 43 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $900,000 | -8.6% | 975,000 | 0.0% | 0.03% | +22.2% |
| Q3 2018 | $985,000 | -24.1% | 975,000 | -33.9% | 0.03% | -28.9% |
| Q2 2018 | $1,297,000 | +8.8% | 1,476,000 | 0.0% | 0.04% | -5.0% |
| Q1 2018 | $1,192,000 | +0.8% | 1,476,000 | 0.0% | 0.04% | 0.0% |
| Q4 2017 | $1,183,000 | +2.4% | 1,476,000 | 0.0% | 0.04% | -2.4% |
| Q3 2017 | $1,155,000 | -19.7% | 1,476,000 | 0.0% | 0.04% | -24.1% |
| Q2 2017 | $1,439,000 | +3.9% | 1,476,000 | 0.0% | 0.05% | +1.9% |
| Q1 2017 | $1,385,000 | +4.4% | 1,476,000 | 0.0% | 0.05% | +6.0% |
| Q4 2016 | $1,326,000 | -19.9% | 1,476,000 | -0.2% | 0.05% | -15.3% |
| Q3 2016 | $1,656,000 | – | 1,479,000 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Worth Venture Partners, LLC | 5,324,000 | $4,995,000 | 3.78% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 57,791,000 | $53,020,000 | 2.12% |
| DLD Asset Management, LP | 32,500,000 | $30,048,000 | 2.06% |
| Castle Creek Arbitrage, LLC | 4,504,000 | $4,161,000 | 1.43% |
| TENOR CAPITAL MANAGEMENT Co., L.P. | 10,000,000 | $9,372,000 | 0.62% |
| Graham Capital Management, L.P. | 14,636,000 | $13,509,000 | 0.60% |
| OAKTREE CAPITAL MANAGEMENT LP | 64,452,000 | $59,704,000 | 0.54% |
| Context Capital Management, LLC | 1,000,000 | $926,000 | 0.52% |
| ADVENT CAPITAL MANAGEMENT /DE/ | 23,118,000 | $21,341,000 | 0.52% |
| WOLVERINE ASSET MANAGEMENT LLC | 18,583,000 | $17,322,000 | 0.21% |